CLINICAL TRIALS PROFILE FOR DAYTRANA
✉ Email this page to a colleague
All Clinical Trials for DAYTRANA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00434213 ↗ | Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA | Completed | Noven Therapeutics | Phase 4 | 2007-01-01 | This is a study designed to characterize the dermal response of DAYTRANA. Subjects will visit the study site over a period of approximately 14 weeks. |
NCT00499863 ↗ | Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD | Completed | Noven Therapeutics | Phase 3 | 2007-07-01 | To assess the efficacy and safety of efficacy of MTS compared to placebo |
NCT00501293 ↗ | Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD | Completed | Noven Therapeutics | Phase 3 | 2007-08-01 | To evaluate the long-term, safety of Methylphenidate Transdermal System (MTS) in aged 13-17 years diagnosed withADHD |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DAYTRANA
Condition Name
Clinical Trial Locations for DAYTRANA
Trials by Country
Clinical Trial Progress for DAYTRANA
Clinical Trial Phase
Clinical Trial Sponsors for DAYTRANA
Sponsor Name